Cite
MLA Citation
Mark N. Stein et al.. “Phase II Trial of Eribulin in Patients With Metastatic Hormone Refractory Prostate Cancer.” American journal of clinical oncology, vol. 42, 2019, p. . http://access.bl.uk/ark:/81055/vdc_100093599252.0x000047